These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30684348)

  • 1. [Acetylsalicylic acid in the prevention and treatment of cardiovascular diseases].
    Łabuz-Roszak B; Horyniecki M; Łącka-Gaździk B
    Wiad Lek; 2018; 71(8):1608-1614. PubMed ID: 30684348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The place of acetylsalicylic acid in the modern cardiovascular pharmacotherapy].
    Giliarov MIu
    Kardiologiia; 2007; 47(9):90-6. PubMed ID: 18260937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug delivery and therapeutic impact of extended-release acetylsalicylic acid.
    Bliden KP; Patrick J; Pennell AT; Tantry US; Gurbel PA
    Future Cardiol; 2016 Jan; 12(1):45-58. PubMed ID: 26356085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events.
    Bliden KP; Tantry US; Chaudhary R; Byun S; Gurbel PA
    Expert Rev Cardiovasc Ther; 2016 Jul; 14(7):779-91. PubMed ID: 27215735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial.
    de Waha A; Sandner S; von Scheidt M; Boening A; Koch-Buettner K; Hammel D; Hambrecht R; Danner BC; Schöndube FA; Goerlach G; Fischlein T; Schmoeckel M; Oberhoffer M; Schulz R; Walther T; Ziegelhöffer T; Knosalla C; Schönrath F; Beyersdorf F; Siepe M; Attmann T; Misfeld M; Mohr FW; Sievers HH; Joost A; Putman LM; Laufer G; Hamm C; Zeymer U; Kastrati A; Radke PW; Lange R; Cremer J; Schunkert H
    Am Heart J; 2016 Sep; 179():69-76. PubMed ID: 27595681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation.
    Cea Soriano L; Bueno H; Lanas A; García Rodríguez LA
    Thromb Haemost; 2013 Dec; 110(6):1298-304. PubMed ID: 24008261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus.
    Gurbel PA; Bliden KP; Chaudhary R; Patrick J; Liu F; Chen G; McLeod C; Tantry US
    Am J Cardiol; 2016 Dec; 118(12):1941-1947. PubMed ID: 27769511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary prevention with clopidogrel or acetylsalicylic acid after acute cerebrovascular event. Health services research study of private primary care specialists].
    Sander D; Schwertfeger M; Köfüncü E; Diehm C; Pittrow D
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1773-8. PubMed ID: 18767003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy and anticoagulation in patients with hypertension.
    Griffin G
    Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet agents and anticoagulants for hypertension.
    Lip GY; Felmeden DC
    Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy in the prevention of cardiovascular diseases.
    Mannucci PM; Cimminiello C; Cattaneo M
    Ann Ital Med Int; 1993; 8(3):189-94. PubMed ID: 8217485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylsalicylic acid in primary prevention of cardiovascular disease.
    Miklík R; Jiravský O
    Vnitr Lek; 2022; 68(4):240-245. PubMed ID: 36220422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family practice patients' use of acetylsalicylic acid for cardiovascular disease prevention.
    Kolber M; Sharif N; Marceau R; Szafran O
    Can Fam Physician; 2013 Jan; 59(1):55-61. PubMed ID: 23341662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
    Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
    Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between low-dose acetylsalicylic acid reinitiation and the risk of myocardial infarction or coronary heart disease death.
    Sáez ME; González-Pérez A; Johansson S; Himmelmann A; García Rodríguez LA
    Eur J Prev Cardiol; 2016 Jul; 23(10):1029-36. PubMed ID: 26603743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for the prevention of cardiovascular morbidity.
    Sanchez-Ross M; Waller AH; Maher J; Klapholz M; Haider B; Kaluski E
    Minerva Med; 2010 Aug; 101(4):205-14. PubMed ID: 21030934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.